跳至主要内容
临床试验/NCT05204433
NCT05204433Unknown不适用

Correlation Between Methylation Site of SFRP1 Gene Promoter and Colorectal Cancer and Adenoma

Xijing Hospital of Digestive Diseases1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2019年1月5日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
220
试验地点
1
主要终点
effectiveness of methylation markers from stool samples

研究概览

简要总结

In summary, our study demonstrated the methylation sites of SFRP1 gene promoter in patients with colorectal cancer and adenoma and found SFRP1_16_17_18 CpG site was good performance as a diagnostic marker of colorectal cancer.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • consecutive adult patients undergoing an outpatient endoscopy and histopathologically diagnosed as colorectal cancer or adenoma. Also, healthy individuals were invited to be enrolled.

排除标准

  • Lynch syndrome
  • Familial adenomatous polyposis
  • MUTYH associated polyposis
  • Peutz-Jeghers syndrome
  • Juvenile polyposis syndrome
  • Serrated polyposis syndrome

结局指标

主要结局

effectiveness of methylation markers from stool samples

时间窗: 3 years

assess the effectiveness of methylation markers from stool samples in colon cancer patients, colorectal adenoma patients, compared with normal volunteers

次要结局

  • assess the capacities of RF model in screening potential clinical biomarkers.(3 years)

研究者

发起方
Xijing Hospital of Digestive Diseases
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jie Liang

Professor

Xijing Hospital of Digestive Diseases

研究点 (1)

Loading locations...

相似试验